Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer

Caleb J. Smith, Tanios S. Bekaii-Saab, Kathryn D. Cook, Rachel A. Eiring, Thorvardur R. Halfdanarson, Mina Hanna, Zhaohui Jin, Jacob A. Jochum, Wen Wee Ma, Jessica L. Mitchell, Henry C. Pitot, Aminah Jatoi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences